The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi, H; Waked, I; Sarrazin, C; P Myers, R; Idilman, R; Calinas, F; Vogel, W; C Mendes Correa, M; Hézode, C; Lázaro, P; Akarca, U; Aleman, S; Balık, I; Berg, T; Bihl, F; Bilodeau, M; J Blasco, A; E Brandão Mello, C; Bruggmann, P; Buti, M; L Calleja, J; Cheinquer, H; B Christensen, P; Clausen, M; S M Coelho, H; E Cramp, M; J Dore, G; Doss, W; S Duberg, A; H El-Sayed, M; Ergör, G; Esmat, G; Falconer, K; Félix, J; L G Ferraz, M; R Ferreira, P; Frankova, S; García-Samaniego, J; Gerstoft, J; A Giria, J; L Gonçales, F; Gower, E; Gschwantler, M; Guimarães Pessôa, M; J Hindman, S; Hofer, H; Husa, P; Kåberg, M; D E Kaita, K; Kautz, A

doi:10.1111/jvh.12248

Public

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Shared by NobleBlocks on May 1, 2014 • 12:00 AM UTC

Authors:

H Razavi

I Waked

C Sarrazin

Abstract

The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total ...

Subject

HCV

diagnosis

disease burden

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!